THE ROLE OF BLOOD GROUPS IN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS

被引:2
|
作者
Karagoz, Hatice [1 ]
Erden, Abdulsamet [2 ]
Ozer, Ozerhan [2 ]
Cetinkaya, Ali [2 ]
Avci, Deniz [2 ]
Gencer, Vedat [2 ]
Arik, Ferhat [2 ]
Kalan, Ugur [2 ]
Gorkem, Hasan [2 ]
Karaman, Hatice [3 ]
Karaman, Ahmet [1 ]
机构
[1] Acibadem Kayseri Hosp, Dept Internal Med, Kayseri, Turkey
[2] Kayseri Training & Res Hosp, Dept Internal Med, Kayseri, Turkey
[3] Kayseri Training & Res Hosp, Dept Clin Pathol, Kayseri, Turkey
来源
ACTA MEDICA MEDITERRANEA | 2017年 / 33卷 / 02期
关键词
ABO; Blood Groups; Non-alcoholic Fatty Liver Disease; Non-alcoholic Steatohepatitis; PREECLAMPSIA; RISK; SEVERITY; FEATURES; FIBROSIS;
D O I
10.19193/0393-6384_2017_2_030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Non-alcoholic fatty liver disease is defined as the accumulation of fat in the liver in the absence of excessive alcohol consumption or other known pathologies and is a spectrum of disease ranging from steatosis (fat infiltration into the liver) to steatohepatitis. Non-alcoholic steatohepatitis is a more severe form of Non-alcoholic fatty liver disease which is characterised by steatosis, lobular inflammation, ballooning, and fibrosis in liver biopsies. In this study, we aimed to investigate any possible relationship between the ABO/Rh blood group system and Non-alcoholic fatty liver disease /Non-alcoholic steatohepatitis, in Turkey. Materials and methods: A total of 179 patients with hepatosteatosis from Kayseri Training and Research Hospital between the years 2002-2012 were included in the study. The distributions of blood groups of the patients with Non-alcoholic fatty liver disease were compared with the distribution of blood groups of 17.314 healthy donors. The patients were examined for any association between ABO/Rh blood groups and Non-alcoholic fatty liver disease /Non-alcoholic steatohepatitis, and also for an association between ABO/Rh blood groups and grading. Results: Group AB was found to be higher in patients with Non-alcoholic fatty liver disease compared to the control group (p=0.04). The percentage of patients with steatohepatitis was significantly higher in group AB than non-AB blood group (p=0.024). The percentage of patients with steatohepatitis was significantly higher in group grade 3 Non-alcoholic fatty liver disease patients than other two -grade 1 and grade 2 Non-alcoholic fatty liver disease -groups (<0.001). Conclusion: To our knowledge, this is the first analysis in the literature that investigates the association between the ABO blood groups and Non-alcoholic fatty liver disease /Non-alcoholic steatohepatitis. This epidemiological study can not explain the mechanism behind the blood group effect but may be a light for future studies.
引用
收藏
页码:205 / 210
页数:6
相关论文
共 50 条
  • [41] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Sachiko Hattori
    Kazuomi Nomoto
    Tomohiko Suzuki
    Seishu Hayashi
    Diabetology & Metabolic Syndrome, 13
  • [42] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Hattori, Sachiko
    Nomoto, Kazuomi
    Suzuki, Tomohiko
    Hayashi, Seishu
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [43] Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?
    Lanthier, Nicolas
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (19) : 2184 - 2188
  • [44] UNDERSTANDING RISK FOR NON-ALCOHOLIC STEATOHEPATITIS AND NON-ALCOHOLIC FATTY LIVER DISEASE IN MEDICARE AND MEDICAID CLAIMS
    Nelson, Katherine
    Gellar, Jonathan
    Anderson, Ryan Taylor
    Campbell, Patrick
    Chen, Arnold
    HEPATOLOGY, 2023, 78 : S2146 - S2147
  • [45] Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
    Jeong Woo Kim
    Young-Sun Lee
    Yang Shin Park
    Baek-Hui Kim
    Soo Yeon Lee
    Jong Eun Yeon
    Chang Hee Lee
    Scientific Reports, 10
  • [46] Navigating the Link Between Non-alcoholic Fatty Liver Disease/ Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome
    Gato, Sheila
    Garcia-Fernandez, Vanessa
    Gil-Gomez, Antonio
    Rojas, Angela
    Montero-Vallejo, Rocko
    Munoz-Hernandez, Rocko
    Romero-Gomez, Manuel
    EUROPEAN CARDIOLOGY REVIEW, 2024, 19
  • [47] Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional Aspects
    Schattenberg, Joern M.
    ERNAHRUNGS UMSCHAU, 2015, 62 (02): : M92 - M100
  • [48] Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Senavirathna, Tharani
    Shafaei, Armaghan
    Lareu, Ricky
    Balmer, Lois
    ANTIOXIDANTS, 2024, 13 (04)
  • [49] A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
    Ganguli, Surosree
    DeLeeuw, Peter
    Satapathy, Sanjaya K.
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2019, 11
  • [50] Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
    Daher, Saleh
    Cohen, Namma Lev
    Massarwa, Muhammad
    Mahamid, Mahmud
    Nasser, Mira
    Hazou, Wadi
    Oren, Rani
    Safadi, Rifaat
    Khoury, Tawfik
    PLOS ONE, 2018, 13 (11):